Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.510
-0.050 (-3.21%)
At close: Dec 5, 2025, 4:00 PM EST
1.430
-0.080 (-5.30%)
After-hours: Dec 5, 2025, 7:52 PM EST
Immuron Market Cap
Immuron has a market cap or net worth of $11.42 million as of December 5, 2025. Its market cap has increased by 10.92% in one year.
Market Cap
11.42M
Enterprise Value
7.61M
1-Year Change
10.92%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $11.42M, a decrease of -59.34%. That is a compound annual growth rate of -10.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.80M | -9.28% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |